{"name":"ILIAS Biologics Inc.","slug":"ilias-biologics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxNQjZyQkhEWV94NlotbmFQaWd1UG1sZGFmekNuQjR5Z2Y2WmNza2xielUzNk9rcE1xSldhd2ZqT2xuXzF5eml4aXhnSEtuWkhMSmZwVVcwaHp0eF9BN1hNZVdTTGhZXzBUMC1YU2xndWdTRnk1UUdXbTBVY2ZGVmU4elZheWFOTDJ2am1ULXg4czEtaWpmWjhEUmpESFdsNVZSRjNDTjFrckttLWVzblRzZjQ4azlEV1lLeWdnQ2t3VmRwVlpCUXZPNVhReHFTM2ZJYUFJRVZhbmhpaGRLMHVqOXlTWXFmalNfdTllb0pOejF4bVlLYWNF?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Exosomes Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com","headline":"Exosomes Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNMEM0S2RNSkg5N2h3NExOWWF0ZFRkTlBFXzFiN2tfWGIyNUJaWkluQ3NsN3BrVE5xbEdaeHZNMFJkRjgtZVU4RU90eENnbmxSaFIyWjlkM0RGSTYwc1NRQUY3cHZxSGdnekNWR3BKWmZmWXphMHh1NlJlc0poSHBYOGxmdnU0YW9VeS05RDZvMDBkd2pHTVZDc2dwQ2IwdUQ3d1lfTkFENHd2N2ZuazVUQTJ0RUFGQjNXamRkM3JnZnRjVlJEYkJxcjRadVVNTTFWcFNPT2NCOFN4Rjh5ZGRJOVVpSW5TMkNjQ2Q0?oc=5","date":"2025-01-13","type":"trial","source":"prnewswire.com","summary":"Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight - prnewswire.com","headline":"Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1lbXZCWDljQkFVVUZsSkZHd2dIUmpSa1lDRGd5cEhUdHdJSkdNVGJfLS1VaGdZOTRTODZ2TXhOZU9WTy1EUzdYZVBnVjRZdjQxaVROc1UxQTMyM0VLZUJLTUN0WkVVSFNJd0d2RXlXelZydw?oc=5","date":"2024-11-14","type":"pipeline","source":"labiotech.eu","summary":"Six exosome therapy companies driving development in the field - labiotech.eu","headline":"Six exosome therapy companies driving development in the field","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPeThLUHJyLVFiTEZNQV96VlJnRzhXSTh5M1lEanJ6WnE3Sy05RXcyLXRYZGJRbExnSk5BdTdudjhKd1FCMUZjejduNUt0Uy1NTVZ4UEhONjZ0WVNwMmxRNEh6RnNmNm9yZ2NqM2xTZTFJVzQ1RzBaR1RLdFdCRG5FNnZRcldIdU5ic0NvZy11UEk0THR5Vmo2ZDI2VGVyaWhic3Y1Zm1ka2s5ZE1xcDhPd2NVWkUxUGVzc0JIVlFiOVZHejZudmpfRWZVUGlFM2tfcVlnMC1aczV6YjhoUk13NDRVbURFbXVLM1E?oc=5","date":"2024-11-04","type":"pipeline","source":"prnewswire.com","summary":"Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - prnewswire.com","headline":"Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPd3duWlFZcnJ5VUpJTmRLbVRGTkl2aEVHVk9JZ2lMa2h6YXNCVnQ3a0ZQZnYzVnlFQlhHdmItNGI1NUJQSTdUa0EyZFZRSWJqRTQ0dnZsZTdnZFFhNXZDdVEtNFdWclZfNmZzcE5MYXBlT2JnMmV3NVR4QWhyRlNraWZoSllBYnIxbkkwc0puUE9KWnIxcnc0QmFpeHJUN2dOeWpmTFp2TnNKU1ExZTZBdG1iN1BxWkVsM053OVppNHFkdF84V2dnUkVqQmxpeGR1S2MxZEI2MWhfczZmSnh4XzhyclQ?oc=5","date":"2024-10-29","type":"pipeline","source":"GlobeNewswire","summary":"Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire","headline":"Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQSXdJSEFKelFTY0VQRjA1ZUdKMmsyWU9nUXIwcW5TV25FYnYydzN3ZE9DVU1aOTcyYnQ0YjB1U1hnS1FZdE93QmFZM1hkbkE3Z19ERG02WkZvNjNPdUV0enNQb1BaSVVibUs2N0V6Y2twUjlKMGZBdklHdDd0UmY2QVBXb29adzFwYlBGWWFoc0tFX3VaV3F1VHFZcUd0WmQ3TlhhYnZnZnhobWFDTW5aMWY5Z192U3dwZ3ZsTm5zLS1IZzhnSWpSMHN1VEY4aFFiOXp6MmFQakFlMEJ2X0pTTDlBMFpiQlRRcmRxT1BBaTlzZ0FYQkxiU0hDSVliZG9zTVlJTjNR?oc=5","date":"2022-04-07","type":"regulatory","source":"BioSpace","summary":"ILIAS Biologics Inc. Receives HREC Approval to Initiate First-in-Human Clinical Trial Evaluating Exosome Therapeutics ILB-202, the Treatment for CSA-AKI - BioSpace","headline":"ILIAS Biologics Inc. Receives HREC Approval to Initiate First-in-Human Clinical Trial Evaluating Exosome Therapeutics IL","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiSkFVX3lxTE82ZkNJS3NiZnpEZXQyQmdXMElFY2F1UTFkcjY5SFdxdmgzd3VwR1RuMVZDZWQ2bENaZXA3QW9DV3d3ZHM2d0gzbEhn?oc=5","date":"2020-01-11","type":"pipeline","source":"BioInformant","summary":"Exosomes: Company Spotlights from \"A\" to \"Z\" - BioInformant","headline":"Exosomes: Company Spotlights from \"A\" to \"Z\"","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}